Back to mobile site

Stanford Group Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy

July 22, 2008 8:22 AM EDT Send to a Friend
Stanford Group initiates coverage on Rigel Pharmaceuticals (Nasdaq: RIGL) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login